BioSpace News Archive

Kaiser Permanente, the nation’s largest integrated health system, committed up to $1.65 million to support relief and recovery efforts in communities affected by the recent California wildfires.

AVEO Oncology (NASDAQ:AVEO) today announced a six-month extension to the interest only period under its existing amended and restated loan and security agreement with Hercules Capital, Inc. (Hercules).

Team brings experience, expertise to future health system

Centene Corporation announced today that Cynthia Brinkley, Chief Administrative & Markets Officer for Centene, has advised the company of her intention to retire, effective February 15, 2019.

Cerus Corporation (Nasdaq:CERS) announced today the issuance of a new U.S. Food and Drug Administration (FDA) draft guidance document on bacterial risk control strategies for platelet collection and transfusion.

The American Pharmacists Association (APhA) applauds recommendations made in a new Trump Administration report that would allow pharmacists and other healthcare providers to practice at the top of their professions and be paid directly for their patient care services.

Innovent Biologics, Inc. announced today that its IND application for IBI101, a recombinant fully human anti-OX40 monoclonal antibody (mAb) drug candidate, has been approved by the US Food & Drug Administration (FDA), and plans to initiate the US phase I clinical trial based on results from the China phase I study in patients with advanced solid tumors.

Introducing “HyperStemTM”

Takeda Pharmaceutical Company Limited today announced the results of the shareholder votes at its Extraordinary General Meeting of Shareholders (“EGM”) regarding the recommended acquisition of Shire plc.